trending Market Intelligence /marketintelligence/en/news-insights/trending/CBqI5p8FaLJTKVtEz82gsw2 content esgSubNav
In This List

WAVE Life Sciences adds board member

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


WAVE Life Sciences adds board member

WAVE Life Sciences Ltd. appointed Adrian Rawcliffe as an independent director, effective Feb. 1.

Rawcliffe, who is CFO of Adaptimmune Therapeutics plc, was also appointed to serve as a member of the WAVE Life Sciences board's audit committee.

Further, Takeshi Wada stepped down from the company's board, effective Jan. 31. He will continue to serve WAVE as a scientific adviser.